Hantz Financial Services Inc. Makes New Investment in Bath & Body Works, Inc. (NYSE:BBWI)

Hantz Financial Services Inc. bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 11,346 shares of the company's stock, valued at approximately $440,000.

A number of other institutional investors also recently added to or reduced their stakes in BBWI. FMR LLC increased its position in shares of Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company's stock worth $80,315,000 after purchasing an additional 2,501,828 shares in the last quarter. KBC Group NV lifted its stake in Bath & Body Works by 9,023.5% in the third quarter. KBC Group NV now owns 1,701,813 shares of the company's stock valued at $54,322,000 after buying an additional 1,683,160 shares during the last quarter. Erste Asset Management GmbH acquired a new stake in shares of Bath & Body Works in the third quarter valued at approximately $50,483,000. Assenagon Asset Management S.A. grew its position in shares of Bath & Body Works by 723.4% during the third quarter. Assenagon Asset Management S.A. now owns 1,167,554 shares of the company's stock worth $37,268,000 after acquiring an additional 1,025,757 shares during the last quarter. Finally, Senvest Management LLC acquired a new position in shares of Bath & Body Works in the 3rd quarter valued at $30,537,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Price Performance

NYSE BBWI traded down $0.06 on Wednesday, reaching $38.74. The company had a trading volume of 2,086,404 shares, compared to its average volume of 2,962,495. The firm has a market capitalization of $8.39 billion, a PE ratio of 9.45, a P/E/G ratio of 1.01 and a beta of 1.83. The firm has a 50-day moving average of $37.67 and a 200-day moving average of $33.61. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings results on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.48 earnings per share. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works's payout ratio is 19.51%.

Analyst Ratings Changes

Several brokerages have issued reports on BBWI. JPMorgan Chase & Co. boosted their price objective on shares of Bath & Body Works from $39.00 to $41.00 and gave the company a "neutral" rating in a research note on Friday, January 24th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Wells Fargo & Company raised Bath & Body Works from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $42.00 to $48.00 in a report on Friday, January 10th. Piper Sandler raised their price target on Bath & Body Works from $36.00 to $39.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Monday, November 25th. One analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.